source
- FDA releases draft PDUFA VIII commitment letter outlining goals and enhancements for 2028-2032The FDA on Thursday issued a proposed commitment letter for the upcoming PDUFA VIII cycle, which will cover fiscal years 2028 through 2032. The letter sets out the agency's performance targets for…
- FDA grants emergency use authorization for Simparica TRIO to treat New World screwworm in dogs and puppiesThe U.S. Food and Drug Administration issued an Emergency Use Authorization for Simparica TRIO, a chewable tablet containing sarolaner, moxidectin and pyrantel, to treat New World screwworm infesta…